Publication Listing for the MeSH term Parp-1. Found 6 abstracts
Karpova Y, Wu C, Divan A, McDonnell ME, Hewlett E, Makhov P, Gordon J, Ye M, Reitz AB, Childers WE, Skorski T, Kolenko V, Tulin AV. Non-NAD-like PARP-1 inhibitors in prostate cancer treatment. Biochemical pharmacology. 2019 Sep;167:149-62. PMCID: PMC6702078 |
Thomas C, Ji Y, Wu C, Datz H, Boyle C, MacLeod B, Patel S, Ampofo M, Currie M, Harbin J, Pechenkina K, Lodhi N, Johnson SJ, Tulin AV. Hit and run versus long-term activation of PARP-1 by its different domains fine-tunes nuclear processes. Proc Natl Acad Sci U S A. 2019 May 14;116(20):9941-6. PMCID: PMC6525528 |
Kotova E, Tulin AV. High-Throughput Colorimetric Assay for Identifying PARP-1 Inhibitors Using a Large Small-Molecule Collection. Methods Mol Biol. 2017 Jan;1608:299-312. |
Makhov P, Naito S, Kolenko VM. Testing PARP Inhibitors Using a Murine Xenograft Model. Methods Mol Biol. 2017 Jan;1608:313-20. |
Thomas C, Kotova E, Tulin AV. PARP-1 Interaction with and Activation by Histones and Nucleosomes. Methods Mol Biol. 2017 Jan;1608:255-67. |
Thomas C, Ji Y, Lodhi N, Kotova E, Pinnola AD, Golovine K, Makhov P, Pechenkina K, Kolenko V, Tulin AV. Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo. EBioMedicine. 2016 Nov;13:90-8. PMCID: PMC5264309 |
MeSH cloud from publications including the MeSH term Parp-1
Parp-1
Poly(ADP-ribose)
PARP-1 activation
PARP-1 inhibitor
poly(ADP-ribose)
PARP-1 regulation
Library of small molecule inhibitors
Jil-1 kinase
drosophila
Non-NAD-like PARP-1 inhibitors
Prostate cancer
PARP-1 inhibitors
Parg
Subcutaneous
Mouse
Nucleosome
Nucleosomal histones
Cancer
Histone-dependent PARP-1 regulation
High-throughput colorimetric assay
PARP-1 binding
5f02
protein domains
Cancer cells
Xenograft
Model